Michael Kearney is an accomplished professional in market access and reimbursement strategies, currently serving as Vice President of Market Access at Clairity, Inc. since September 2025. Previously, Kearney held significant roles at GRAIL, where responsibilities included developing innovative reimbursement strategies and co-leading a C-suite working group. At Avalere Health, Kearney directed market access engagements for life sciences and biotech, notably supporting the 2022 launch of CAR-T therapy, which resulted in substantial sales growth. Earlier experience includes leadership in finance and reimbursement at Steward Health Care and strategic consulting at Rusk O'Brien Gido + Partners. Kearney holds a Bachelor's degree in Corporate Finance from Boston College.
This person is not in any teams
This person is not in any offices